| Conclusion and future prospective of polymeric nanoparticles for cancer therapy R Shukla, M Handa, SB Lokesh, M Ruwali, K Kohli, P Kesharwani Polymeric nanoparticles as a promising tool for anti-cancer therapeutics …, 2019 | 54 | 2019 |
| Optimization of surfactant-and cosurfactant-aided pine oil nanoemulsions by isothermal low-energy methods for anticholinesterase activity M Handa, RR Ujjwal, N Vasdev, SJS Flora, R Shukla ACS omega 6 (1), 559-568, 2020 | 45 | 2020 |
| Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer’s disease M Handa, S Tiwari, AK Yadav, WH Almalki, S Alghamdi, KS Alharbi, ... Drug Discovery Today 26 (12), 2881-2888, 2021 | 39 | 2021 |
| Potential of nanoparticulate based delivery systems for effective management of alopecia P Mishra, M Handa, RR Ujjwal, V Singh, P Kesharwani, R Shukla Colloids and Surfaces B: Biointerfaces 208, 112050, 2021 | 37 | 2021 |
| Polycaprolactone based nano-carrier for co-administration of moxifloxacin and rutin and its In-vitro evaluation for sepsis M Handa, A Sharma, RK Verma, R Shukla Journal of drug delivery science and Technology 54, 101286, 2019 | 32 | 2019 |
| Wearable smart devices in cancer diagnosis and remote clinical trial monitoring: Transforming the healthcare applications S Beg, M Handa, R Shukla, M Rahman, WH Almalki, O Afzal, ... Drug discovery today 27 (10), 103314, 2022 | 30 | 2022 |
| Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis R Shukla, A Singh, M Handa, SJS Flora, P Kesharwani Drug Discovery Today 26 (8), 1972-1979, 2021 | 27 | 2021 |
| Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting M Handa, S Beg, R Shukla, MA Barkat, H Choudhry, KK Singh Journal of Controlled Release 340, 48-59, 2021 | 25 | 2021 |
| Nanocarrier mediated autophagy: an emerging trend for cancer therapy A Singh, M Handa, M Ruwali, SJS Flora, R Shukla, P Kesharwani Process Biochemistry 109, 198-206, 2021 | 24 | 2021 |
| Stimuli-responsive polymeric nanosystems for therapeutic applications M Handa, A Singh, SJS Flora, R Shukla Current Pharmaceutical Design 28 (11), 910-921, 2022 | 22 | 2022 |
| Active pharmaceutical ingredients (APIs) in ionic liquids: An effective approach for API physiochemical parameter optimization M Handa, WH Almalki, R Shukla, O Afzal, ASA Altamimi, S Beg, ... Drug Discovery Today 27 (9), 2415-2424, 2022 | 20 | 2022 |
| Introduction to pharmaceutical product development R Shukla, M Handa, VP Pardhi Pharmaceutical drug product development and process optimization, 1-32, 2020 | 16 | 2020 |
| Rosemary oil low energy nanoemulsion: optimization, µrheology, in silico, in vitro, and ex vivo characterization N Vasdev, M Handa, P Kesharwani, R Shukla Journal of Biomaterials Science, Polymer Edition 33 (15), 1901-1923, 2022 | 13 | 2022 |
| Recent nanoengineered diagnostic and therapeutic advancements in management of Sepsis M Soni, M Handa, KK Singh, R Shukla Journal of Controlled Release 352, 931-945, 2022 | 12 | 2022 |
| Lymphatic targeting for therapeutic application using nanoparticulate systems N Singh, M Handa, V Singh, P Kesharwani, R Shukla Journal of Drug Targeting 30 (10), 1017-1033, 2022 | 11 | 2022 |
| Preparation, Characterization, and Evaluation of Curcumin–Graphene Oxide Complex-Loaded Liposomes against Staphylococcus aureus in Topical Disease M Rahman, JG Singh, O Afzal, ASA Altamimi, M Alrobaian, J Haneef, ... ACS omega 7 (48), 43499-43509, 2022 | 11 | 2022 |
| Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease A Dhiman, M Handa, M Ruwali, DP Singh, P Kesharwani, R Shukla Mitochondrion 64, 112-124, 2022 | 10 | 2022 |
| Clinical translation status of nanoformulations R Shukla, K Thok, S Kakade, M Handa, S Beg Nanoformulation strategies for cancer treatment, 303-338, 2021 | 10 | 2021 |
| Dendrimer-based drug delivery systems for tuberculosis treatment R Shukla, A Sethi, M Handa, M Mohan, PK Tripathi, P Kesharwani Nanotechnology based approaches for tuberculosis treatment, 163-174, 2020 | 10 | 2020 |
| Recent highlights on Omicron as a new SARS-COVID-19 variant: evolution, genetic mutation, and future perspectives P Khairnar, M Soni, M Handa, Y Riadi, P Kesharwani, R Shukla Journal of drug targeting 30 (6), 603-613, 2022 | 9 | 2022 |
Rahul Shukla, Ph.DNIPER,Raebareli,India在 niperraebareli.edu.in 的电子邮件经过验证
